Charity campaigns against NICE kidney cancer ruling

The National Kidney Federation (NKF) is to launch a campaign against NICE's decision to rule out the use of four new drugs for kidney cancer.

Last week NICE said that it would not be recommending the use of the drugs Sutent, Avastin, Nexavar and Torisel on the NHS because they were not cost-effective.

The NKF is now demanding an appeal in order to argue against the NICE decision.

The charity will be contacting their members and urging them to approach their MPs about appealing the NICE decision.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins


Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus